title: [Bone health in the oncologic patient].
abstract: Progressive bone loss, resulting in both osteoporosis and osteomalacia, is a frequent long-term complication in cancer patients undergoing common anti-tumor treatment programs. Monitoring of bone health by both imaging techniques and biochemical markers measurement, is useful in preventing the severe skeleton default.
authors.affiliation: Sezione di Medicina Interna e Oncologia Clinica, Dipartimento di Scienze Biomediche e Oncologia Umana, Università Aldo Moro, 70124 Bari.
authors.forename: Stella
authors.initials: S
authors.lastname: D'Oronzo
authors.forename: Antonella
authors.initials: A
authors.lastname: Tamma
authors.forename: Valeria
authors.initials: V
authors.lastname: Simone
authors.forename: Vito
authors.initials: V
authors.lastname: Longo
authors.forename: Franco
authors.initials: F
authors.lastname: Silvestris
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001847:Bone Diseases / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents